Back to News
Market Impact: 0.55

ACN Quantitative Stock Analysis

ACNNDAQ
Company FundamentalsCorporate EarningsCapital Returns (Dividends / Buybacks)Analyst InsightsTechnology & Innovation
ACN Quantitative Stock Analysis

Accenture PLC (ACN) has been rated 85% by Validea's Patient Investor model, which is based on Warren Buffett's investment strategy, signaling interest. This model targets firms with long-term, predictable profitability, low debt, and reasonable valuations, criteria ACN largely satisfies by passing tests for earnings predictability, debt service, return on equity, and free cash flow. The strong fundamental alignment suggests ACN could appeal to long-term, value-oriented investors.

Analysis

Accenture PLC (ACN) has received a high rating of 85% from Validea's Patient Investor model, which is structured on Warren Buffett's investment principles. This score signifies notable interest, as it approaches the 90% threshold for a 'strong interest' designation. The model's positive assessment is rooted in ACN's strong underlying fundamentals, particularly its performance against criteria favoring long-term, predictable profitability and low debt. The company successfully passed key tests for Earnings Predictability, Debt Service, Return on Equity, Return on Total Capital, and Free Cash Flow, indicating robust financial health and operational efficiency. While the profile is overwhelmingly positive, the model assigned a 'NEUTRAL' rating to its Share Repurchase activity, suggesting its capital return policy via buybacks may not be as compelling or value-accretive as other aspects of its financial strategy. Overall, as a large-cap growth stock, ACN demonstrates significant quality and value characteristics that align with a disciplined, long-term investment philosophy.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo